AI cough leader Hyfe is a global leader in AI-powered cough-monitoring technology with a track record across 50+ clinical studies, signaling strong credibility for partnerships with pharma, research institutions, and healthcare providers seeking scalable respiratory data solutions.

Clinical trial enablement The technology supports long-term passive cough monitoring to optimize clinical trial design and endpoints, creating strong sales opportunities with pharmaceutical companies and CROs aiming to improve trial efficiency and data quality.

Healthcare optimization Healthcare providers can leverage continuous cough data to enhance patient care management for chronic and acute respiratory conditions, offering a compelling value proposition for hospitals and clinics seeking telemetry-driven care.

Digital therapeutics Hyfe’s platform can power digital therapeutics and remote patient monitoring programs, aligning with emerging payer and provider initiatives to expand remote respiratory care and cost-effective management.

Strategic partnerships With global pharma and leading academic institutions as long-term partners, Hyfe presents a ready-made path to co-development, joint studies, and enterprise deployments, signaling potential for enterprise-scale opportunities and channel partnerships.